No photo of Lorenzo Gallon

View Scopus Profile

Lorenzo Gallon

  • 3405 Citations
1993 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

I am currently the Medical Director of the Translational Medicine Program, the Director of International Relations and the Director of the Renal Transplant Fellowship. My primary research interests are: Role of immunosuppressive medications in modulating the immune system, Genomic of chronic renal allograft rejection, Chronic kidney disease after liver transplant, Prednisone-free and Calcineurin inhibitors free immunosuppressive protocols, new immunosuppressive strategies, FSGS, Aging and impact of physical exercise after kidney transplantation, tolerance induction.

Certifications and Licenses

Nephrology

Training Experience

1998Residency, Brigham & Women's Hospital
1999Fellowship, Brigham & Women's Hospital

Education/Academic qualification

MD, University of Padua

… → 1991

Research interests

  • Immune Regulation
  • Immunology
  • Kidney
  • Translational Research
  • Transplantation

Fingerprint Dive into the research topics where Lorenzo Gallon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 29 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Prot. CCFZ533A2201: A 12 month, partially-blinded, active-controlled, multicenter, randomized study evaluating efficacy, safety, tolerability, pharmacokinetic (PK) and pharmacodynamic (PD) of an anti-CD40 monoclonal antibody, CFZ533, in de novo and mainte

Gallon, L.

Novartis Pharmaceuticals Corporation

1/15/20 → 5/12/26

Project: Research project

Uncovering the circulating factor in FSGS

Gallon, L., Jin, J. & Wertheim, J. A.

U.S. Army Medical Research and Materiel Command

9/30/18 → 3/31/21

Project: Research project

    • Prot. 7163-CL-3201: A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de novo Kidney Transplant Recipients

    Gallon, L.

    Astellas Pharma Global Development, Inc.

    10/13/17 → 10/13/20

    Project: Research project

    Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients

    Gallon, L. & Stosor, V.

    University of California, San Francisco, National Institute of Allergy and Infectious Diseases

    2/1/16 → 1/31/21

    Project: Research project

    • Randomized Conversion of EBV+ Kidney Transplant Recipients of Living or Standard Criteria Donors at Three Months Post Transplantation to Belatacept with MPA or Belatacept with Low-Dose Tacrolimus (50% of Dose) Compared to Patients Remaining on Center Spec

    Gallon, L. & Leventhal, J. R.

    Bristol-Myers Squibb Company

    9/9/14 → 9/9/22

    Project: Research project

    Research Output

    A peripheral blood gene expression signature to diagnose subclinical acute rejection

    Zhang, W., Yi, Z., Keung, K. L., Shang, H., Wei, C., Cravedi, P., Sun, Z., Xi, C., Woytovich, C., Farouk, S., Huang, W., Banu, K., Gallon, L., Magee, C. N., Najafian, N., Samaniego, M., Djamali, A., Alexander, S. I., Rosales, I. A., Smith, R. N. & 8 others, Xiang, J., Lerut, E., Kuypers, D., Naesens, M., O’connell, P. J., Colvin, R., Menon, M. C. & Murphy, B., Aug 2019, In : Journal of the American Society of Nephrology. 30, 8, p. 1481-1494 14 p.

    Research output: Contribution to journal › Article

    • 9 Scopus citations

    Circulating B cells with memory and antibody-secreting phenotypes are detectable in pediatric kidney transplant recipients before the development of antibody-mediated rejection

    Fischman, C., Fribourg, M., Fabrizio, G., Cioni, M., Comoli, P., Nocera, A., Cardillo, M., Cantarelli, C., Gallon, L., Petrosyan, A., Da Sacco, S., Perin, L. & Cravedi, P., Jan 1 2019, In : Transplantation Direct. 5, 9, e481.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations

    Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen-Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil

    Traitanon, O., Mathew, J. M., Shetty, A., Bontha, S. V., Maluf, D. G., El Kassis, Y., Park, S. H., Han, J., Ansari, M. J., Leventhal, J. R., Mas, V. & Gallon, L., May 2019, In : PloS one. 14, 5, e0216300.

    Research output: Contribution to journal › Article

    Open Access
    • 2 Scopus citations

    Pretransplant transcriptomic signature in peripheral blood predicts early acute rejection

    Zhang, W., Yi, Z., Wei, C., Keung, K. L., Sun, Z., Xi, C., Woytovich, C., Farouk, S., Gallon, L., Menon, M. C., Magee, C., Najafian, N., Samaniego, M. D., Djamali, A., Alexander, S. I., Rosales, I. A., Smith, R. N., O’Connell, P. J., Colvin, R., Cravedi, P. & 1 others, Murphy, B., Jun 6 2019, In : JCI Insight. 4, 11, e127543.

    Research output: Contribution to journal › Article

    Open Access
    • 4 Scopus citations

    Recent advances of biosensors for hypertension and nephrology

    Park, S. H., Zhang, Y., Rogers, J. A. & Gallon, L., Jul 1 2019, In : Current opinion in nephrology and hypertension. 28, 4, p. 390-396 7 p.

    Research output: Contribution to journal › Review article

    • 1 Scopus citations